Elite Pharmaceuticals Inc (ELTP)

[kayak_wench]

Nope I'm bowing out this discussion.
I really don't care about people posting the Narsat Mikah crap anymore. I am just going to tell them to take it to court and let us know how it turns out.

I'll leave the part about the value of trimipramine to Elite. As it highlights how these people do not think about anything before they make their claims. Again, Nasrat just a few weeks ago highlighted trimipramine as one of the stand out legacy products that they want to quickly fold into their private marketing. Meaning not only was it not a bad deal, it continues to be a profitable product.

Its not hard to take a guess at how profitable. Manufacturing costs are low because there is nothing special about its API.

The estimated cost to manufacture trimipramine is $50–$150 per patient per year.
Lets call that $150 per year to worst case it.
Best price for patients right now is about 50cents a pill, but averages a dollar and its taken 1 to 3 times a day.
I wam going to assume a price of 75cents per day or about $300 a year.
So Elite can sell it for at least twice what it costs to manufacture.
The market is pretty much 100% generic at this point.
At the estimated sales from 8 years ago (before price increased by 2 to three times, so this is very much low balling it) that would be $1M in revenue of which $500k would be pure profit.
It is obvious at that profit rate trimipramine generated at least $2.5M in the past five years. More than making the purchase at a bit over $1M worth it. But again that is based on old sales numbers. The cost has increased a good bit as the drug has become less used.